Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Ting

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Future Oncology (London, England)|June 20, 2014
Mdm2 protein expression is strongly associated with survival in malignant pleural mesotheliomaFabian D Mairinger, Robert F H Walter, Saskia Ting, et al.
International Journal of Cancer|September 18, 2021
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer-Stromal gene expressions show higher prognostic values than intrinsic tumor genesCsilla Olah, Christina Hahnen, Nikolett Nagy, et al.
JCO Clinical Cancer Informatics|August 1, 2023
Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep LearningFabian Hörst, Saskia Ting, Sven-Thorsten Liffers, et al.
Cancer Medicine|October 7, 2022
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancerCsilla Olah, Henning Reis, Michèle J Hoffmann, et al.
Oncology Research and Treatment|January 9, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, et al.
Cancers|April 30, 2021
Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma EyesEva Biewald, Tobias Kiefer, Dirk Geismar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 31, 2014
Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling studyFabian Dominik Mairinger, Saskia Ting, Robert Werner, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2020
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancerTimm M Reissig, Linda Sara, Saskia Ting, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 22, 2022
Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancerJulius Keyl, René Hosch, Aaron Berger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2022
<sup>18</sup>F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in MenPedro Fragoso Costa, Lukas Püllen, Claudia Kesch, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|June 20, 2014
Mdm2 protein expression is strongly associated with survival in malignant pleural mesotheliomaFabian D Mairinger, Robert F H Walter, Saskia Ting, et al.
International Journal of Cancer|September 18, 2021
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer-Stromal gene expressions show higher prognostic values than intrinsic tumor genesCsilla Olah, Christina Hahnen, Nikolett Nagy, et al.
JCO Clinical Cancer Informatics|August 1, 2023
Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep LearningFabian Hörst, Saskia Ting, Sven-Thorsten Liffers, et al.
Cancer Medicine|October 7, 2022
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancerCsilla Olah, Henning Reis, Michèle J Hoffmann, et al.
Oncology Research and Treatment|January 9, 2023
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, et al.
Cancers|April 30, 2021
Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma EyesEva Biewald, Tobias Kiefer, Dirk Geismar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 31, 2014
Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling studyFabian Dominik Mairinger, Saskia Ting, Robert Werner, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2020
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancerTimm M Reissig, Linda Sara, Saskia Ting, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 22, 2022
Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancerJulius Keyl, René Hosch, Aaron Berger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2022
<sup>18</sup>F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in MenPedro Fragoso Costa, Lukas Püllen, Claudia Kesch, et al.
Pageof 6